Mimedx Group: Pay

No proxy on file gives executive pay for Mimedx Group.

No pay on file. Pay comes from the Summary Compensation Table of the proxy statement.

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $7.3M. The CEO of Mimedx Group was paid $7.2M, 2% below the median.

  1. 1Alphatec Holdings
  2. 2Adma Biologics
  3. 3Veracyte
  4. 4Mimedx Group
  5. 5CareDx
  6. 6Artivion
  7. 7Angiodynamics
  8. 8AVITA Medical, Inc.Not disclosed
  9. 9Anika TherapeuticsNot disclosed
  10. 10Axonics, Inc.Not disclosed
  11. 11Bioventus Inc.Not disclosed
  12. 12Integra Life Sciences Holdings CorporationNot disclosed
  13. 13OraSure Technologies, Inc.Not disclosed
  14. 14Organogenesis Holdings Inc.Not disclosed
  15. 15Orthofix MedicalNot disclosed
  16. 16Outset Medical, Inc.Not disclosed
  17. 17Standard BioTools Inc.Not disclosed
  18. 18Tactile Systems Technology, Inc.Not disclosed
  19. 19VericelNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.